| Literature DB >> 15063567 |
Bettina Langhans1, Ingrid Braunschweiger, Susann Schweitzer, Tilman Sauerbruch, Ulrich Spengler.
Abstract
We analysed whether hepatitis C virus (HCV)-specific antibody producing B lymphocytes can be induced in vitro with HCV-derived lipopeptides containing different T helper cell epitopes. HCV-specific antibody producing B cells were detected by ELISPOT at the single cell level. HCV-derived lipopeptides, but not their corresponding unlipidated peptides, induced B lymphocytes, which produced antibodies mainly reacting with the HCV-derived lipopeptides. The number of antigen-specific B cells was dependent on the number of added autologous T helper lymphocytes during the incubation period. Thus, HCV lipopeptides are more immunogenic than unmodified peptides and can induce HCV-reactive B lymphocytes in antigen-naïve lymphocytes.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15063567 DOI: 10.1016/j.vaccine.2003.10.014
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641